ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.150
-0.050 (-1.56%)
Sep 18, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.35 billion as of September 18, 2026. Its market cap has decreased by -71.16% in one year.
Market Cap
1.35B
Enterprise Value
665.26M
Revenue
170.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.15
ChartMarket Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.35B, a decrease of -81.42%. That is a compound annual growth rate of -42.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.35B | -46.20% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.89B |
| Guangzhou Innogen Pharmaceutical Group | 1.76B |
| Mabpharm | 1.61B |
| SinoMab BioScience | 1.56B |
| Shandong Boan Biotechnology | 1.52B |
| Beijing Biostar Pharmaceuticals | 1.49B |
| Zhaoke Ophthalmology | 1.37B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |